Therapeutic area
Background info
Indication
Advantages
Intellectual property
Owner/lead
What the technology does
REXER: Incorporation of large (up to 100mb) of synthetic DNA into the E. coli chromosome.
Advantage
Efficient and single step in vivo insertion or replacement of more than 100 kb synthetic DNA into the E. coli chromosome, including replacement of entire operon and genome. 100% integration at target locus.
Main application field
Genome engineering of E. coli
Usage
Research Tool
Status
Technology ready for evaluation.
Intellectual Property
Patent application filed in July 2016
Offering
Exclusive or non-exclusive licence